Giant cell arteritis with polymyalgia rheumatica

GIANT_CELL_TEMP_ARTERITIS

polymyalgia rheumatica: Polymyalgia rheumatica is a common inflammatory condition that often affects people over the age of 50 years. Characteristic symptoms are shoulder and hip girdle pain and prolonged morning stiffness. Markers of inflammation are often elevated.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 M31.5
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 M31.5
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

702

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

702

diagram downward connector

Check minimum number of events None

702

diagram downward connector

Include endpoints None

702

diagram downward connector
GIANT_CELL_TEMP_ARTERITIS

Extra metadata

First used in FinnGen datafreeze DF2
Parent code in ICD-10 M31
Name in latin Arteritis gigantocellularis cum polymyalgia reumatica

Summary Statistics

Key figures

All Female Male
Number of individuals 685 425 260
Unadjusted prevalence (%) 0.22 0.24 0.19
Mean age at first event (years) 68.29 67.61 69.41

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.77 [1.22, 6.25] 1.4e-2 96
15 years 0.01 1.37 [0.66, 2.85] 4.0e-1 38
5 years 0.00 3.80 [2.34, 6.19] 7.3e-8 38
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: GIANT_CELL_TEMP_ARTERITIS – Giant cell arteritis with polymyalgia rheumatica
GWS hits: 0

Survival analyses between endpoints

Plot

before Giant cell arteritis with polymyalgia rheumatica
after Giant cell arteritis with polymyalgia rheumatica

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Giant cell arteritis with polymyalgia rheumatica